ANIP
ANI Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website anipharmaceuticals.com
- Employees(FY) 600
- ISIN US00182C1036
Performance
+2.23%
1W
-3.71%
1M
+1.16%
3M
-11.36%
6M
+7.29%
YTD
+17.61%
1Y
Profile
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Technical Analysis of ANIP 2024-12-10
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-06 09:40
- 2024-12-03 19:00
ANIP: Lowering target price to $60.00(Argus Research)
- 2024-12-02 14:21
- 2024-11-29 03:32
- 2024-11-26 19:00
ANIP: Raising target price to $61.00(Argus Research)
- 2024-11-26 16:30
- 2024-11-26 09:55
- 2024-11-26 03:30
- 2024-11-20 12:00
- 2024-11-20 09:40
- 2024-11-18 16:08
- 2024-11-14 09:40
- 2024-11-12 19:00
ANIP: Raising target price to $64.00(Argus Research)
- 2024-11-10 08:30
- 2024-11-09 04:00
- 2024-11-08 10:00
- 2024-11-08 08:05
- 2024-11-08 07:20
- 2024-11-08 06:58
ANI: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-11-08 06:50
- 2024-11-07 19:21
- 2024-11-07 17:50
- 2024-11-07 07:06
- 2024-11-05 19:00
ANIP: Lowering target price to $60.00(Argus Research)
- 2024-11-04 16:30
- 2024-11-04 03:30
- 2024-11-01 10:00
- 2024-10-30 17:00
- 2024-10-30 05:00
- 2024-10-25 08:00
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.